Mathieu Meunier

Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes

Mathieu Meunier, Sarah Ancelet, Christine Lefebvre et al. · Oncotarget · 2017 · 37 citations · Full text

Medicine, Hematology, Molecular Medicine +16

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status

Sophie Servais, Nicolas Dumontier, Lucie Biard et al. · Clinical Microbiology and Infection · 2015 · 24 citations · Full text

Medicine, Hematology, Immunology +14

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes

Sophie Park, Olivier Kosmider, Frédéric Maloisel et al. · Haematologica · 2018 · 24 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

Jean‐Baptiste Bossard, Jean‐Baptiste Beuscart, Marie Robin et al. · American Journal of Hematology · 2020 · 23 citations · Full text

Medicine, Hematology, Surgery +13

NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells

Julie Brault, Bénédicte Vigne, Mathieu Meunier et al. · Free Radical Biology and Medicine · 2019 · 20 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17